Although the Supreme Court has recently increased its review of patent laws, the rulings have only eliminated deviations and reinforced precedent. However, the implications for nutraceutical companies is that their patent applications would have to represent a true invention and be very precise, rather than being a collection of scientific facts or trivial improvements. In his byline on www.nutraingredients-usa.com, Foley’s John Garvey discusses three recent cases reviewed by the Supreme Court and the impact of these decisions on dietary supplement and functional foods companies looking to patent their technologies.
Related Insights
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
July 21, 2025
Energy Current
DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now
Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
July 21, 2025
Labor & Employment Law Perspectives
Considering a Reduction in Force? Some Preliminary Considerations
Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…